Skip to main content

Advertisement

Log in

Long-Term Weight Outcome After Bariatric Surgery in Patients with Melanocortin-4 Receptor Gene Variants: a Case–Control Study of 105 Patients

  • Original Contributions
  • Published:
Obesity Surgery Aims and scope Submit manuscript

Abstract

Introduction

Pathogenic heterozygous MC4R variants are associated with hyperphagia and variable degrees of obesity. Several research groups have reported short-term weight loss outcomes after bariatric surgery in a few patients with MC4R variants, but lack of longer-term data prevents evidence-based clinical decision-making.

Materials and Methods

Bariatric surgery patients with heterozygous (likely) pathogenic MC4R variants, from three collaborating centers in the Netherlands, France, and the UK, were compared to matched controls (matched 2:1 for age, sex, preoperative BMI, surgical procedure, and diabetes mellitus, but without MC4R mutations). Weight loss and regain outcomes up to 6 years of follow-up were compared.

Results

At 60 months of follow-up after RYGB, cases with MC4R variants showed weight regain with a mean of 12.8% (± 10.4 SD) total weight loss (TWL) from nadir, compared to 7.9% (± 10.5 SD) in the controls (p = 0.062). Among patients receiving SG, the cases with MC4R variants experienced inferior weight loss (22.6% TWL) during the first year of follow-up compared to the controls (29.9% TWL) (p = 0.010).

Conclusions

This multicenter study reveals inferior mid-term weight outcomes of cases with MC4R variants after SG, compared to RYGB. Since adequate weight loss outcomes were observed after RYGB, this procedure would appear to be an appropriate surgical approach for this group. However, the pattern of weight regain seen in cases with MC4R variants after both RYGB and SG highlights the need for pro-active lifelong management to prevent relapse, as well as careful expectation management.

Graphical abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Dogan K, Betzel B, Homan J, et al. Long-term effect of laparoscopic Roux-en-Y gastric bypass on diabetes mellitus, hypertension and dyslipidaemia in morbidly obese patients. Obes Surg. 2014;24:1835–42. https://doi.org/10.1007/s11695-014-1310-2.

    Article  CAS  PubMed  Google Scholar 

  2. le Roux CW, Heneghan HM. Bariatric surgery for obesity. Med Clin N Am. 2018;108:165–82. https://doi.org/10.1016/j.mcna.2017.08.011.

    Article  Google Scholar 

  3. Felsenreich DM, Langer FB, Kefurt R, et al. Weight loss, weight regain and conversions to Roux-en-Y gastric bypass: 10 year results of laparoscopic sleeve gastrectomy. Surg Obes Relat Dis. 2016;12(9):1655–62. https://doi.org/10.1016/j.soard.2016.02.021.

    Article  PubMed  Google Scholar 

  4. Lubrano-Berthelier C, Dubern B, Lacorte JM, et al. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype-phenotype relationship, and lack of association with binge eating. J Clin Endocrinol Metab. 2006;91(5):1811–8. https://doi.org/10.1210/jc.2005-1411.

    Article  CAS  PubMed  Google Scholar 

  5. Larsen LH, Echwald SM, Sorensen TI, Andersen T, Wulff BS, Pedersen O. Prevalence of mutations and functional analyses of melanocortin 4 receptor variants identified among 750 men with juvenile-onset obesity. J Clin Endocrinol Metab. 2005;90(1):219–24. https://doi.org/10.1210/jc.2004-0497.

    Article  CAS  PubMed  Google Scholar 

  6. Stutzmann F, Tan K, Vatin V, et al. Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes. 2008;57(9):2511–8. https://doi.org/10.2337/db08-0153.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Vaisse C, Clement K, Durand E, Hercberg S, Guy-Grand B, Froguel P. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J Clin Investig. 2000;106(2):253–62. https://doi.org/10.1172/JCI9238.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Hatoum IJ, Stylopoulos N, Vanhoose AM, et al. Melanocortin-4 receptor signaling is required for weight loss after gastric bypass surgery. J Clin Endocrinol Metab. 2012;97(6):E1023–31. https://doi.org/10.1210/jc.2011-3432.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Farooqi IS, Keogh JM, Yeo GS, Lank EJ, Cheetham T, O’Rahilly S. Clinical spectrum of obesity and mutations in the melanocortin-4-receptor gene. N Engl J Med. 2003;348:1085–95. https://doi.org/10.1056/NEJMoa022050.

    Article  CAS  PubMed  Google Scholar 

  10. Demiralp DO, Berberoglu M, Akar N. Melanocortin-4 receptor polymorphisms in Turkish pediatric obese patients. Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 2011;17(1):70–4. https://doi.org/10.1177/1076029609354330.

    Article  CAS  Google Scholar 

  11. van den Berg L, van Beekum O, Heutink P, et al. Melanocortin-4 receptor gene mutations in a Dutch cohort of obese children. Obesity. 2011;19(3):604–11. https://doi.org/10.1038/oby.2010.259.

    Article  CAS  PubMed  Google Scholar 

  12. Hainerova I, Larsen LH, Holst B, et al. Melanocortin 4 receptor mutations in obese Czech children: studies of prevalence, phenotype development, weight reduction response, and functional analysis. J Clin Endocrinol Metab. 2007;92(9):3689–96. https://doi.org/10.1210/jc.2007-0352.

    Article  CAS  PubMed  Google Scholar 

  13. Aslan YR, Ranadive SA, Ersoy BA, Rogers SJ, Lustig RH, Vaisse C. Bariatric surgery outcome in a patient with complete MC4R deficiency. Int J Obes. 2011;35(3):457–61. https://doi.org/10.1038/ijo.2010.168.

    Article  CAS  Google Scholar 

  14. Jelin EB, Daggag H, Speer AL, et al. Melanocortin-4 receptor signaling is not required for short-term weight loss after sleeve gastrectomy in pediatric patients. Int J Obes. 2016;40:550–3. https://doi.org/10.1038/ijo.2015.230.

    Article  CAS  Google Scholar 

  15. Censani M, Conroy R, Deng L, et al. Weight loss after bariatric surgery in morbidly obese adolescents with MC4R mutations. Obesity. 2014;22(1):225–31. https://doi.org/10.1002/oby.20511.

    Article  CAS  PubMed  Google Scholar 

  16. Valette M, Poitou C, Le Beyec J, Bouillot JL, Clement K, Czernichow S. Melanocortin-4 receptor mutations and polymorphisms do not affect weight loss after bariatric surgery. PLoS ONE. 2012;7(11): e48221. https://doi.org/10.1371/journal.pone.0048221.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Moore BS, Mirshahi UL, Yost EA, et al. Long-term weight-loss in gastric bypass patients carrying melanocortin 4 receptor variants. PLoS ONE. 2014;9(4): e93629. https://doi.org/10.1371/journal.pone.0093629.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Elkhenini HF, New JP, Syed AA. Five-year outcome of bariatric surgery in a patient with melanocortin-4 receptor mutation. Clinical Obesity. 2014;4:121–4. https://doi.org/10.1111/cob.12051.

    Article  CAS  PubMed  Google Scholar 

  19. Aslan YR, Campos GM, Calton MA, Evans DS, Merriman RB, Vaisse C. Weight loss after Roux-en-Y gastric bypass in obese patients heterozygous for MC4R mutations. Obes Surg. 2011;21:930–4. https://doi.org/10.1007/s11695-010-0295-8.

    Article  PubMed  Google Scholar 

  20. Cooiman MI, Kleinendorst L, Aarts EO, et al. Genetic obesity and bariatric surgery outcome in 1014 patients with morbid obesity. Obes Surg. 2019.https://doi.org/10.1007/s11695-019-04184-w

  21. Li Y, Zhang H, Tu Y, et al. Monogenic obesity mutations lead to less weight loss after bariatric surgery: a 6-year follow-up study. Obes Surg. 2019;29(4):1169–73. https://doi.org/10.1007/s11695-018-03623-4.

    Article  PubMed  Google Scholar 

  22. Kleinendorst L, Massink MPG, Cooiman MI, et al. Genetic obesity: next-generation sequencing results of 1230 patients with obesity. J Med Genet. 2018;(0):1-9.https://doi.org/10.1136/jmedgenet-2018-105351

  23. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association of molecular pathology. Genet Med. 2015;17(5):405–24. https://doi.org/10.1038/gim.2015.30.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Brethauer SA, Kim J, el Chaar M, et al. Standardized outcomes reporting in metabolic and bariatric surgery. Surg Obes Relat Dis. 2015;11(3):489–506. https://doi.org/10.1016/j.soard.2015.02.003.

    Article  PubMed  Google Scholar 

  25. van de Laar AW, van Rijswijk AS, Kakar H, Bruin SC. Sensitivity and specificity of 50% excess weight loss (50% EWL) and twelve other bariatric criteria for weight loss success. Obes Surg. 2018. https://doi.org/10.1007/s11695-018-3173-4.

    Article  PubMed  Google Scholar 

  26. Shoar S, Saber A. Long-term and midterm outcomes of laparoscopic sleeve gastrectomy versus Roux-en-Y gastric bypass: a systematic review and meta-analysis of comparative studies. Surg Obes Relat Dis. 2016; 00–00. Doi: https://doi.org/10.1016/j.soard.2016.08.011

  27. Karmali S, Brar B, Shi X, Sharma AM, de Gara C, Birch DW. Weight recidivism post-bariatric surgery: a systematic review. Obes Surg. 2013;23(11):1922–33. https://doi.org/10.1007/s11695-013-1070-4.

    Article  PubMed  Google Scholar 

  28. Shantavasinkul PC, Omotosho P, Corsino L, Portenier D, Torquati A. Predictors of weight regain in patients who underwent Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2016;12(9):1640–5. https://doi.org/10.1016/j.soard.2016.08.028.

    Article  PubMed  Google Scholar 

  29. Voorwinde V, Steenhuis IHM, Janssen IMC, Monpellier VM, Stralen van MM. Definitions of long-term weight regain and their associations with clinical outcome. Obes Surg. 2020;30:527–36. https://doi.org/10.1007/s11695-019-04210-x.

    Article  PubMed  Google Scholar 

  30. Homan J, Boerboom A, Aarts E, et al. A longer biliopancreatic limb in Roux-en Y gastric bypass improves weight loss in the first years after surgery: results of a randomized controlled trial. Obes Surg. 2018. https://doi.org/10.1007/s11695-018-342.

    Article  PubMed  Google Scholar 

  31. Thereaux J, Corigliano N, Poitou C, Oppert J-M, Czernichow S, Bouillot J-L. Comparison of results after one year between sleeve gastrectomy and gastric bypass in patients with BMI≥50 kg/m2. Surgery for Obesity and Related Diseases. 2015;11(4):785–90. https://doi.org/10.1016/j.soard.2014.11.022.

    Article  PubMed  Google Scholar 

  32. Thereaux J, Veyrie N, Bardsmisn C, et al. Similar postoperative safety between primary and revisional gastric bypass for failed gastric banding. JAMA Surg. 2014;149(8):780–6. https://doi.org/10.1001/jamasurg.2014.625.

    Article  PubMed  Google Scholar 

  33. Dijkhorst PJ, Boerboom AB, Janssen IMC, et al. Failed sleeve gastrectomy: single anastomosis duodenoileal bypass or Roux-en-Y gastric bypass? A multicentre cohort study Obes Surg. 2018. https://doi.org/10.1007/s116965-018-3429-z.

    Article  Google Scholar 

  34. Miras AD, Kamocka A, Tan T, et al. Long limb compared with standard limb Roux-en-Y gastric bypass for type 2 diabetes and obesity: the LONG LIMB RCT. Efficacy Mech Eval 2021;8(3). Doi: https://doi.org/10.3310/eme08030

  35. Saleh M, Cheruvu MS, Moorthy K, Ahmed AR. Laparoscopic sleeve gastrectomy using a synthetic bioabsorbable staple line reinforcement material: post-operative complications and 6 year outcomes. Ann Med Surg. 2016;10:83–7. https://doi.org/10.1016/j.amsu.2016.08.005.

    Article  Google Scholar 

  36. Aarts EO, Dogan K, Koehestanie P, Aufenacker ThJ, Janssen IMC, Berends FJ. Long-term results after laparoscopic adjustable gastric banding: a mean fourteen year follow-up study. Surgery for Obesity and Related Diseases. 2014. https://doi.org/10.1016/j.soard.2014.03.019.

    Article  PubMed  Google Scholar 

  37. Allen RE, Hughes TD, Ng JL, et al. Mechanisms behind the immediate effects of Roux-en-Y gastric bypass surgery on type 2 diabetes. Theor Biol Med Model. 2013;10:45. https://doi.org/10.1186/1742-4682-10-45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Pucci A, Batterham RL. Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different. J Endocrinol Invest. 2019;42:117–28. https://doi.org/10.1007/s40618-018-0892-2.

    Article  CAS  PubMed  Google Scholar 

  39. Wadden TA, Tronieri JS, Sugimoto D, et al. Liraglutide 3.0 mg and intensive behavioral therapy (BIT) for obesity in primary care: the SCALE IBT randomized controlled trial. Obesity 2020;28(3):529–536. Doi: https://doi.org/10.1002/oby.22726.

  40. Collet TH, Dubern B, Mokrosinski J, et al. Evaluation of a melanocortin-4 receptor (MC4R) agonist (setmelanotide) in MC4R deficiency. Mol Metab. 2017;6(10):1321–9. https://doi.org/10.1016/j.molmet.2017.06.015.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Clement K, van den Akker E, Argente J, et al. Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trial. Lancet Diabetes&Endocrinology. 2020. https://doi.org/10.1016/S2213-8587(20)30364-8.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to special thank S.M. Oussaada, MD, for her help in the conceptualization of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Mellody I. Cooiman or Mieke M. van Haelst.

Ethics declarations

Ethical Approval

All procedures performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Conflict of Interest

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Key points

• Inferior weight loss was identified after SG in patients with MC4R variants.

• RYGB appears to be an appropriate surgical approach for patients with MC4R variants.

• Patients with an MC4R variant showed weight regain after both surgical procedures.

• Pro-active lifelong management to prevent relapse is important.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 40 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cooiman, M.I., Alsters, S.I.M., Duquesnoy, M. et al. Long-Term Weight Outcome After Bariatric Surgery in Patients with Melanocortin-4 Receptor Gene Variants: a Case–Control Study of 105 Patients. OBES SURG 32, 837–844 (2022). https://doi.org/10.1007/s11695-021-05869-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11695-021-05869-x

Keywords

Navigation